GSK plc Statistics

Total Valuation

GSK plc has a market cap or net worth of BRL 546.96 billion. The enterprise value is 641.18 billion.

Market Cap	546.96B
Enterprise Value	641.18B

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	Feb 19, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.60%
Shares Change (QoQ)	-0.39%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	87.63%
Float	3.86B

Valuation Ratios

The trailing PE ratio is 12.91 and the forward PE ratio is 11.03.

PE Ratio	12.91
Forward PE	11.03
PS Ratio	2.26
PB Ratio	4.62
P/TBV Ratio	n/a
P/FCF Ratio	11.54
P/OCF Ratio	9.53
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.22, with an EV/FCF ratio of 13.53.

EV / Earnings	15.13
EV / Sales	2.91
EV / EBITDA	8.22
EV / EBIT	10.04
EV / FCF	13.53

Financial Position

The company has a current ratio of 0.82, with a Debt / Equity ratio of 1.11.

Current Ratio	0.82
Quick Ratio	0.50
Debt / Equity	1.11
Debt / EBITDA	1.54
Debt / FCF	2.78
Interest Coverage	14.36

Financial Efficiency

Return on equity (ROE) is 43.31% and return on invested capital (ROIC) is 26.53%.

Return on Equity (ROE)	43.31%
Return on Assets (ROA)	9.79%
Return on Invested Capital (ROIC)	26.53%
Return on Capital Employed (ROCE)	23.78%
Weighted Average Cost of Capital (WACC)	5.60%
Revenue Per Employee	3.62M
Profits Per Employee	633,949
Employee Count	66,841
Asset Turnover	0.54
Inventory Turnover	1.54

Taxes

In the past 12 months, GSK plc has paid 8.24 billion in taxes.

Income Tax	8.24B
Effective Tax Rate	15.02%

Stock Price Statistics

The stock price has increased by +28.73% in the last 52 weeks. The beta is 0.35, so GSK plc's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	+28.73%
50-Day Moving Average	56.95
200-Day Moving Average	48.16
Relative Strength Index (RSI)	34.72
Average Volume (20 Days)	10

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GSK plc had revenue of BRL 242.17 billion and earned 42.37 billion in profits. Earnings per share was 10.29.

Revenue	242.17B
Gross Profit	175.84B
Operating Income	70.03B
Pretax Income	54.87B
Net Income	42.37B
EBITDA	84.03B
EBIT	70.03B
Earnings Per Share (EPS)	10.29

Balance Sheet

The company has 25.36 billion in cash and 131.86 billion in debt, giving a net cash position of -106.50 billion.

Cash & Cash Equivalents	25.36B
Total Debt	131.86B
Net Cash	-106.50B
Net Cash Per Share	n/a
Equity (Book Value)	118.28B
Book Value Per Share	30.26
Working Capital	-28.77B

Cash Flow

In the last 12 months, operating cash flow was 57.39 billion and capital expenditures -9.99 billion, giving a free cash flow of 47.39 billion.

Operating Cash Flow	57.39B
Capital Expenditures	-9.99B
Depreciation & Amortization	12.77B
Net Borrowing	8.56B
Free Cash Flow	47.39B
FCF Per Share	n/a

Margins

Gross margin is 72.61%, with operating and profit margins of 28.92% and 17.50%.

Gross Margin	72.61%
Operating Margin	28.92%
Pretax Margin	22.66%
Profit Margin	17.50%
EBITDA Margin	34.70%
EBIT Margin	28.92%
FCF Margin	19.57%

Dividends & Yields

This stock pays an annual dividend of 1.80, which amounts to a dividend yield of 3.31%.

Dividend Per Share	1.80
Dividend Yield	3.31%
Dividend Growth (YoY)	5.74%
Years of Dividend Growth	2
Payout Ratio	17.52%
Buyback Yield	0.60%
Shareholder Yield	3.87%
Earnings Yield	7.75%
FCF Yield	8.66%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GSK plc has an Altman Z-Score of 2.04 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.04
Piotroski F-Score	7